Dipeptidyl peptidase-4 (DPP-4) inhibitors mitigate cardiovascular risks by attenuating high-fat-diet-induced dysbiosis, promoting the abundance of SCFAs-producing microbiota, and reducing the Bacteroidetes to Firmicutes ratio (Zhang et al., 2023)
10.1016/S0887-8994(02)00460-5 Shapiro YG, Gutman A: Muscle carnitine deficiency in patients using valproic acid
*Ozempic, Mounjaro, Rybelsus, Victoza, and Trulicity are FDA-approved for type 2 diabetes, not weight loss
They offer a practical way to provide nutrients that can help support your goals, without requiring you to eat large volumes of food
tyroksyna - w trakcie jednoczesnego stosowania dochodzi do zwikszenia cakowitej ekspozycji, dlatego zaleca si monitorowanie czynnoci tarczycy